Background illustration for clinical trials search

Paid Clinical Trials Little Rock

Discover 471 paid clinical trials in Little Rock, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

for
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder,
Location: Little Rock AR, Memphis TN, Rogers AR, O'Fallon MO,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07172516

Phase3, Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for
High Risk Cardiovascular Disease, Hypertension,
Location: Little Rock AR, Olive Branch MS, Shreveport LA,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07181109

Phase3, Recruiting

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Bryant AR, Flowood MS, St Louis MO,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07114874

Phase3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Little Rock AR, Memphis TN, Springfield MO,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Little Rock AR, Springdale AR, Paducah KY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

for
Tardive Dyskinesia
Location: Little Rock AR, Oklahoma City OK, Kansas City MO,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT03062033

Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Little Rock AR, Memphis TN, West Monroe LA, Jackson TN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase3, Recruiting

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Bryant AR, DeSoto TX, Houston TX,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT06963034

Phase3, Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for
Endometrial Cancer
Location: Little Rock AR, Springfield MO, Shreveport LA,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase3, Recruiting
New

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Bentonville AR, Richardson TX,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 18 - 65

Code: NCT07686263

Phase3, Recruiting

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

for
Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder
Location: Little Rock AR, Plano TX, Saint Charles MO,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06229210

Phase3, Recruiting

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

for
Irritability Associated With Autism Spectrum Disorder
Location: Little Rock AR, Shreveport LA, Oklahoma City OK,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06706674

Phase3, Recruiting

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Richardson TX, Decatur GA, DeLand FL,
Sponsor: Leal Therapeutics, Inc

Sex: All

Age: 18 - 55

Code: NCT07734493

Phase1, Recruiting

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

for
Bipolar I Disorder
Location: Little Rock AR, Bentonville AR, Richardson TX,
Sponsor: LB Pharmaceuticals Inc.

Sex: All

Age: 18 - 65

Code: NCT07494305

Phase2, Recruiting

A Study of Brenipatide in Adult Participants With Schizophrenia

for
Schizophrenia
Location: Little Rock AR, St Louis MO, DeSoto TX, Fort Worth TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 55

Code: NCT07410507

Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Little Rock AR, Rogers AR, Flowood MS, Richardson TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06951711

Phase3, Recruiting

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Rogers AR, Bentonville AR,
Sponsor: Reviva Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT05184335

Phase3, Recruiting

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

for
Metabolic Dysfunction-associated Steatohepatitis
Location: Little Rock AR, St Louis MO, Dallas TX, Arlington TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07701993

Phase3, Recruiting

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

for
Metabolic Dysfunction-associated Steatohepatitis
Location: Little Rock AR, St Louis MO, Dallas TX, Arlington TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07704892

Phase3, Recruiting

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Little Rock AR, Bastrop LA, Springfield MO, Dallas TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221227

Phase3, Recruiting